These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31892254)

  • 21. MiRNA Biogenesis and Regulation of Diseases: An Overview.
    Vishnoi A; Rani S
    Methods Mol Biol; 2017; 1509():1-10. PubMed ID: 27826912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics.
    Huang W
    Methods Mol Biol; 2017; 1617():57-67. PubMed ID: 28540676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized medicine in neurodegenerative diseases: how far away?
    Gotovac K; Hajnšek S; Pašić MB; Pivac N; Borovečki F
    Mol Diagn Ther; 2014 Feb; 18(1):17-24. PubMed ID: 24122102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
    Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
    Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
    Wang WX; Fardo DW; Jicha GA; Nelson PT
    Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.
    Li J; Lei K; Wu Z; Li W; Liu G; Liu J; Cheng F; Tang Y
    Oncotarget; 2016 Jul; 7(29):45584-45596. PubMed ID: 27329603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
    Basak I; Patil KS; Alves G; Larsen JP; Møller SG
    Cell Mol Life Sci; 2016 Feb; 73(4):811-27. PubMed ID: 26608596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.
    Du L; Pertsemlidis A
    J Mol Cell Biol; 2011 Jun; 3(3):176-80. PubMed ID: 21278200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs (miRNAs) in neurodegenerative diseases.
    Nelson PT; Wang WX; Rajeev BW
    Brain Pathol; 2008 Jan; 18(1):130-8. PubMed ID: 18226108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of the microRNA network cause neurodegenerative disease.
    Hébert SS; De Strooper B
    Trends Neurosci; 2009 Apr; 32(4):199-206. PubMed ID: 19268374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application.
    Alexandri C; Daniel A; Bruylants G; Demeestere I
    Hum Reprod Update; 2020 Feb; 26(2):174-196. PubMed ID: 32074269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
    Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
    Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
    Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
    Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
    [No Abstract]   [Full Text] [Related]  

  • 39. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
    He M; Zhang HN; Tang ZC; Gao SG
    Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.